2nd May 2006 16:23
GlaxoSmithKline PLC02 May 2006 Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons I give below details of changes in the interests of Directors, PersonsDischarging Managerial Responsibility or Connected Persons in the OrdinaryShares of GlaxoSmithKline plc. The Administrators of the GlaxoSmithKline US Retirement Savings Plan ("the Plan") notified GlaxoSmithKline plc on 2 May 2006, that as a result of a movement in the fund on 27 April 2006, the number of Ordinary Share ADRs held by the fund had changed from 17,507,831 to 17,432,485 at a price of $53.01. The Plan is a discretionary fund of which all employees or former employees ofGlaxoSmithKline plc and its subsidiaries are potential beneficiaries. Two of theCompany's directors, Dr J P Garnier and Dr T Yamada are therefore potentiallyinterested in the shares held in the fund from time to time in the same way asother employees or former employees of GlaxoSmithKline plc and its subsidiaries. This notification relates to a transaction notified in accordance withDisclosure Rule 3.1.4R(1)(b). S M BicknellCompany Secretary 2 May 2006 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Glaxosmithkline